✨ Onyx Summary Phathom Pharmaceuticals announced that its management team will present at the Cantor Global Healthcare Conference on September 3 and the H.C. Wainwright Global Investment Conference on September 8, 2025, with live webcasts and replays available on the company’s website. Management will also participate in one-on-one investor
✨ Onyx Summary Kyverna Therapeutics announced that CEO Warner Biddle will participate in fireside chats at the 2025 Wells Fargo, Morgan Stanley, and H.C. Wainwright Global Healthcare Conferences in early September. The presentations will be webcast live via Kyverna’s investor relations website, with replays available for 90 days. EMERYVILLE,
“We can make fully renewable, even carbon-negative gasoline - but the market isn’t built for it yet.” Verde Clean Fuels is transforming wasted energy into profit while cutting lifecycle emissions by up to 35%.
✨ Onyx Summary Phathom Pharmaceuticals clarified that an upcoming Schedule 13D filing by Frazier Life Sciences reflects only administrative reporting changes and does not reduce Frazier’s ownership in the company. By affirming that no shares have been sold, Phathom underscores continued investor commitment at a pivotal time in advancing its
✨ Onyx Summary Keros Therapeutics received U.S. FDA Orphan Drug designation for KER-065 for the treatment of Duchenne muscular dystrophy, recognizing its potential to address a rare and serious condition with limited therapies. The designation provides regulatory and financial incentives as Keros advances KER-065 toward a planned Phase 2 trial
✨ Onyx Summary Rocket Pharmaceuticals announced that the FDA has lifted the clinical hold on its pivotal Phase 2 trial of RP-A501 for Danon disease, allowing the study to resume at a recalibrated lower dose with updated safety protocols. The swift resolution marks a key milestone for one of the most
✨ Onyx Summary Nucleus RadioPharma appointed former FDA Commissioner Dr. Stephen M. Hahn as chief executive officer to lead its expansion in radiopharmaceutical manufacturing and infrastructure. Backed by $72 million in funding and partnerships with Eclipse, Mayo Clinic, and AstraZeneca, Hahn will focus on scaling GMP readiness, expanding R&D,
✨ Onyx Summary SpyGlass Pharma appointed Elizabeth (Liz) O’Farrell, former Eli Lilly executive, to its Board of Directors as Independent Director and Chair of the Audit Committee. O’Farrell’s extensive background in finance, governance, and global operations strengthens SpyGlass’s leadership as it advances its long-acting ophthalmic drug delivery
✨ Onyx Summary ImmunityBio has launched a Phase 2 clinical trial to evaluate ANKTIVA®, its IL-15–based immunotherapy, in patients with long COVID, a condition affecting an estimated 1 in 5 U.S. adults after SARS-CoV-2 infection. The exploratory study will primarily assess safety, with secondary and exploratory measures including effects
“Recycling is basically urban mining for value,” TerraCycle rethinks recycling economics, makes hard-to-recycle items profitable, and champions reuse as the only practical path to eliminating the idea of waste.
“To make climate tech work, it’s all about economics and scale,” With cement and concrete making up 8% of global CO₂, Fortera’s bolt-on tech locks in carbon, keeps costs flat, and hits full strength in two days.
✨ Onyx Summary Legend Biotech appointed Carlos Santos as Chief Financial Officer, succeeding interim CFO Jessie Yeung. Santos, formerly CFO for U.S. Oncology at AstraZeneca, brings global finance leadership across pharma and tech sectors to support Legend’s goal of achieving profitability in 2026 while advancing its CAR-T franchise, including
✨ Onyx Summary Geron Corporation granted inducement equity awards to 11 new hires covering 522,000 shares—348,000 stock options with a $1.45 exercise price and 10-year term, and 174,000 RSUs—granted on August 15, 2025 under Nasdaq Listing Rule 5635(c)(4), with options and RSUs vesting
“This is the first time in hydro history that there is no compromise between biodiversity and power production.” Bill Malus explains how Natel Energy’s FishSafe™ turbines deliver 98–100% fish survival without sacrificing efficiency.
✨ Onyx Summary Guardant Health announced the grant of 239,565 restricted stock units to 189 new employees and stock options for 23,542 shares to two additional hires under its 2023 Employment Inducement Incentive Award Plan. These equity awards not only serve as a material inducement for attracting top talent
✨ Onyx Summary VeriSIM Life announced that its Founder and CEO, Dr. Jo Varshney, received the 2025 International Women Entrepreneur Award in IT from Great Companies, recognizing her leadership in applying AI-driven biosimulation to transform drug development. Dr. Varshney’s work with the company’s BIOiSIM® platform—capable of predicting human
